Journals / Kırıkkale Üniversitesi Tıp Fakültesi Dergisi / 2020 / Cilt: 22 - Sayı: 3

Intracellular Pharmacokinetic Properties of Antibiotics

ANTİBİYOTİKLERİN HÜCRE İÇİ FARMAKOKİNETİK ÖZELLİKLERİ

Pages
470–477
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, the aim is to give information about the intracellular pharmacokinetic properties of antibiotics used in the treatment of diseases caused by intracellular pathogenic bacteria.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pathogenic bacteria that have the ability to enter and multiply in the cell, cause a large number of diseases.
📊
Key Findings & Data:If the intracellular pH is below 6, some antibiotics retain their antibacterial activity, while others lose it.
💡
Conclusion & Impact:In this review, the aim is to give information about the intracellular pharmacokinetic properties of antibiotics used in the treatment of diseases caused by intracellular pathogenic bacteria.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Antibiyotik · Dağılım · Efluks

Abstract

Pathogenic bacteria that have the ability to enter and multiply in the cell, cause a large number of diseases. In order to obtain efficient results from the antibiotics used in the treatment of these diseases, intracellular pharmacokinetic values should be taken into consideration as well as plasma pharmacokinetic parameters. Thus, drugs used in treatment of diseases caused by intracellular pathogens have to accumulate intracellulary in adequate concentration and time while maintaining their antibacterial activity. However, intracellular pH affects the activity of the antibiotics. If the intracellular pH is below 6, some antibiotics retain their antibacterial activity, while others lose it. In this review, the aim is to give information about the intracellular pharmacokinetic properties of antibiotics used in the treatment of diseases caused by intracellular pathogenic bacteria.

Özet

Hücre içine girebilme ve çoğalabilme kabiliyetine sahip olan patojen bakteriler; çok sayıda hastalığa neden olmaktadır. Bu hastalıkların tedavisinde kullanılan antibiyotiklerden verimli sonuçlar elde edilebilmesi için, plazma farmakokinetik parametreleri yanında hücre içi farmakokinetik değerler de dikkate alınmalıdır. Çünkü hücre içi bu patojen bakterilerin neden olduğu hastalıkların tedavisinde kullanılacak ilacın, uygun hücre içi bölümde birikmesi, antibakteriyel özelliğini muhafaza etmesi, hücre içinde yeterli konsantrasyon ve sürede bulunması gerekmektedir. Ancak hücre içi pH değeri, antibiyotiklerin etkinliğini etkilemektedir. Hücre içi pH değeri 6’nın altındaki değerlerde olursa; bazı antibiyotikler antibakteriyel etkinliğini korurken, bazıları ise kaybetmektedir. Bu derlemede, hücre içi patojen bakterilerin neden olduğu hastalıkların tedavisinde kullanılan antibiyotiklerin, hücre içi farmakokinetik özellikleri hakkında bilgi verilmesi amaçlanmıştır.

🔖

Cite This Article

ŞAHİN, Y., YILDIRIM, E. (2020). Intracellular Pharmacokinetic Properties of Antibiotics. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi, Cilt: 22 - Sayı: 3, 470–477. https://ajindex.com/articles/209542

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Estes L. Review of pharmacokinetics and pharmacodynamics of antimicrobial agents. Mayo Clin Proc. 1998;73(11):1114-22
  2. Urso R, Blardi P, Giorgi G. A short introduction to pharmacokinetics. Eur Rev Med Pharmacol Sci. 2002;6(2-3):33-44
  3. Wang Y, Liu J, Zhang J, Wang L, Chan J, Wang H et al. A cell-based pharmacokinetics assay for evaluating tubulin-binding drugs. Int J Med Sci. 2014;11(5):479-87
  4. Van Bambeke F, Barcia-Macay M, Lemaria S, Tulkens PM. Cellular pharmacodynamics and pharmacokinetics of antibiotics: Current views and perspectives. Curr Opin Drug Discov Devel. 2006;9(2):218-30
  5. Pea F. Intracellular pharmacokinetics of antibacterials and their clinical implications. Clin Pharmacokinet. 2018;57(2):177-89
  6. Kaya S. Farmakokinetik. In: Kaya S, ed. Veteriner Farmakoloji. 6. baskı, 1. Cilt. Ankara. Medisan, 2014:21-84
  7. Castillo JRE. Tetracyclines. In: Giguére S, Prescott JF, Dowling PM, eds. Antimicrobial Therapy in Veterinary Medicine. 5th ed. Lowa. Wiley Blackwell, 2013:257-68
  8. D’Avolio A, Pensi D, Baietto L, Perri GD. Therapeutic drug monitoring of intracellular anti-infective agents. J Pharm Biomed Anal. 2014;101:183-93
  9. Kamaruzzaman NF, Kendall S, Good L. Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections. Br J Pharmacol. 2017;174(1):2225-36
  10. Labro MT. Cellular accumulation of macrolide antibiotics. In: Schonfeld W, Kirst HA eds. Intracellular bioactivity, Macrolide Antibiotics. 1st ed. Basel: Springer. 2002:37-52
  11. Maurin M, Raoult D. Use of aminoglycosides in treatment of infections due to intracellular bacteria. Antimicrob Agents Chemother. 2001;45(11):2977-86
  12. Carryn S, Chanteux H, Seral C, Mingeot-Leclercq MP, Van Bambeke F, Tulkens PM. Intracellular pharmacodynamics of antibiotics. Infect Dis Clin North Am. 2003;17(3):615-34
  13. Hof H. Antibiotic Treatment of Infections with Intracellular Bacteria. In: Paradise LJ, Friedman H, Bendinelli M; eds. Opportunistic Intracellular Bacteria and Immunity. New York. Plenum Press, 1999:281-93
  14. Steinberg TH. Cellular transport of drugs. Clin Infect Dis. 1994;19(5):916-21
  15. Leggett JE. Aminoglycosides. In: Cohen J, Powderly WG, Opal SM, eds. Infectious Diseases. 4th ed. China. Elsevier, 2017:1233-8
  16. Papich MG, Riviere JE. Aminoglycoside Antibiotics. In: Riviere JE, Papich MG, eds. Veterinary Pharmacology and Therapeutics. 10th ed. Hoboken. John Wiley and Sons, 2018:877-902
  17. Jiang M, Karasawa